Company · CIK 1818838

# Adagene Inc.

| CIK | [1818838](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001818838) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Business address | China |
| Listed | ADAG (Nasdaq) |
| First annual or quarterly report | 2021-04-28 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-287161 | Shelf Effective | 2025-05-09 | 2026-04-02 | 5 |
| 333-291196 | Shelf Effective | 2025-10-31 | 2026-01-09 | 2 |
| 333-264486 | Shelf Effective | 2022-04-26 | 2024-03-29 | 3 |
| 333-252210 | IPO Final prospectus | 2021-01-19 | 2021-02-10 | 6 |

## Filings

 18

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-04-02 | [424B5](https://www.sec.gov/Archives/edgar/data/1818838/000110465926039189/0001104659-26-039189-index.htm) Shelf takedown | 333-287161 | 0001104659-26-039189 |
| 2026-04-02 | [424B5](https://www.sec.gov/Archives/edgar/data/1818838/000110465926038861/0001104659-26-038861-index.htm) Shelf takedown | 333-287161 | 0001104659-26-038861 |
| 2026-01-09 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1818838/999999999526000134/9999999995-26-000134-index.htm) Declared effective | 333-291196 | 9999999995-26-000134 |
| 2025-10-31 | [F-3](https://www.sec.gov/Archives/edgar/data/1818838/000110465925104934/0001104659-25-104934-index.htm) Shelf registered | 333-291196 | 0001104659-25-104934 |
| 2025-05-30 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1818838/999999999525001796/9999999995-25-001796-index.htm) Declared effective | 333-287161 | 9999999995-25-001796 |
| 2025-05-30 | [424B5](https://www.sec.gov/Archives/edgar/data/1818838/000110465925054974/0001104659-25-054974-index.htm) Shelf takedown | 333-287161 | 0001104659-25-054974 |
| 2025-05-09 | [F-3](https://www.sec.gov/Archives/edgar/data/1818838/000110465925046772/0001104659-25-046772-index.htm) Shelf registered | 333-287161 | 0001104659-25-046772 |
| 2024-03-29 | [424B5](https://www.sec.gov/Archives/edgar/data/1818838/000110465924041120/0001104659-24-041120-index.htm) Shelf takedown | 333-264486 | 0001104659-24-041120 |
| 2022-05-26 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1818838/999999999522001602/9999999995-22-001602-index.htm) Declared effective | 333-264486 | 9999999995-22-001602 |
| 2022-04-26 | [F-3](https://www.sec.gov/Archives/edgar/data/1818838/000110465922050362/0001104659-22-050362-index.htm) Shelf registered | 333-264486 | 0001104659-22-050362 |
| 2021-02-10 | [424B4](https://www.sec.gov/Archives/edgar/data/1818838/000104746921000331/0001047469-21-000331-index.htm) Final prospectus | 333-252210 | 0001047469-21-000331 |
| 2021-02-08 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1818838/999999999521000506/9999999995-21-000506-index.htm) Declared effective | 333-252543 | 9999999995-21-000506 |
| 2021-02-08 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1818838/999999999521000497/9999999995-21-000497-index.htm) Declared effective | 333-252210 | 9999999995-21-000497 |
| 2021-02-05 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1818838/000104746921000297/0001047469-21-000297-index.htm) Amendment | 333-252210 | 0001047469-21-000297 |
| 2021-02-03 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1818838/000104746921000256/0001047469-21-000256-index.htm) Amendment | 333-252210 | 0001047469-21-000256 |
| 2021-02-01 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1818838/000104746921000233/0001047469-21-000233-index.htm) Amendment | 333-252210 | 0001047469-21-000233 |
| 2021-01-19 | [F-1](https://www.sec.gov/Archives/edgar/data/1818838/000104746921000130/0001047469-21-000130-index.htm) Registration filed | 333-252210 | 0001047469-21-000130 |
| 2020-09-22 | [DRS](https://www.sec.gov/Archives/edgar/data/1818838/000110465920107433/0001104659-20-107433-index.htm) Draft made public | 377-03582 | 0001104659-20-107433 |

[All filings of this company](https://equitycapital.markets/filings?cik=1818838) · [CSV](https://equitycapital.markets/filings.csv?cik=1818838)

---
Source page: https://equitycapital.markets/company/1818838 · Data: U.S. SEC EDGAR · CC BY 4.0